Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
Novo Nordisk’s introduction of an affordable oral GLP-1 medication provides a new option for weight management, potentially increasing market reach an...
Read Full Article →